Viral in Biological Technology
Navigation Links
Viral in Biological Technology
Viral Genetics Creates Subsidiary to Develop Cancer Therapy
... 7 /PRNewswire-FirstCall/ -- Biotechnology company viral Genetics (Pink Sheets: VRAL) has formed a wholly ... for many years helped develop the process for viral Genetics. "The results are consistently ... resistant tumors," said Haig Keledjian, CEO of viral Genetics. "Dr. Trauger has worked in the biotech ...InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
... There was no evidence of viral rebound during ITMN-191 treatment in any cohort. ... that the combination resulted in sustained viral load reductions over the dosing period in all ... the topics of the PK/PD profile (#1594) and the viral resistance profile (#1585) of the INFORM-1 ...Pharmasset to Present at Canaccord Adams Conference
... and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the ... which act as alternative substrates for the viral polymerase thus inhibiting viral replication. We currently have three ...Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights
... were reported at the EASL conference. The median viral load reduction over three days ranged from 2.4 to ... No patient at any dose level showed evidence of viral rebound while on ANA598 and there were no serious ... second quarter the Company reported evidence of viral load reduction in a majority of patients who ...... ("California/04"), which was one of the original viral strains selected by the WHO for vaccine ... protection against different circulating viral strains," said Andy Sheldon, President and CEO of ... recently made a new set of seed strains using new viral isolates, such as the California/07, in hopes of ...
Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009
... (GSK) on new drugs for the treatment of viral diseases, Santaris Pharma is responsible for the ... Phase IIa ("Clinical Proof of Concept") for four viral targets, at which point GlaxoSmithKline will have ... a worldwide basis. Presently GSK has selected one viral disease target and Santaris Pharma has identified ...... Calif., July 13 /PRNewswire-FirstCall/ -- viral Genetics (Pink Sheets: VRAL), a biotechnology ... in shares of common stock of the company. Since viral Genetics' February 17, 2009 Form 8-K report, the ... of these notes. Since March 2009, viral Genetics has issued shares in exchange for ...
Viral Genetics Information Now Available Through OTCIQ.com and Pink Sheets Website
... 8 /PRNewswire-FirstCall/ -- Biotechnology company viral Genetics (Pink Sheets: VRAL) has begun making ... market. Investors can access and download all viral Genetics financial reports, current reports, and ... other requirements. Doing so will be dependent on viral Genetics securing sufficient resources to ...... today successful independent testing for bovine viral diarrhoea (BVD) by the Veterinary Laboratories ... tests could be deployed for the related viral diseases, such as classical swine fever, with ... as TB in cattle, bacterial infections and other viral infections, such as foot and mouth disease and ...
... 10.7% in the 15 mcg/day group. Defining viral response at Weeks 12 and 24 with INFERGEN and RBV ... for these patients was the analysis regarding viral response at 12 weeks. In the DIRECT trial, 81.3% and 63.6% of patients achieving viral negativity at Week 12 went on to have an SVR in ...
... help the immune system fight infection. HIV-1 viral particles that use the CCR5 coreceptor to infect ... from HIV diagnostic testing to monitoring HIV viral load, determining a viral genotype, and testing for the HLA-B*5701 genetic ...
... that harness the apoptotic ability of the sindbis viral vector, today announced that Frank Stonebanks, ... titled "Cynvec: Breakthrough Oncolytic viral Vector Therapy with Sindbis" at the 11th Annual ... based on the apoptotic sindbis oncolytic viral vector, a novel technology that targets the over ...
Pharmasset Reports Fiscal Second Quarter 2009 Financial Results
... and commercializing novel drugs to treat viral infections, reported financial results and ... and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the ... which act to inhibit the enzymes required for viral replication. We currently have three ...InterMune Reports First Quarter 2009 Financial Results and Business Highlights
... q8h cohorts, respectively. ITMN-191 delivered viral kinetic performance that is comparable to the ... experiments. There was no evidence of viral rebound during ITMN-191 treatment in any cohort. ... The combination resulted in sustained viral load reductions over the dosing period in all ...Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights
... at all dose levels. At 200 mg bid, the median viral load reduction was 2.4 log10 (range of 0.4 to ... the 12 genotype 1a patients who received ANA598, viral load was still declining at the end of the three ... bid, respectively. No patient showed evidence of viral rebound while on ANA598. ANA598 was ...... development of drugs for the treatment of human viral diseases, today reported data from its three ... nucleoside metabolite concentrations in serum and viral load reductions in this study. Trough serum ... between levels of NM and HCV RNA, with greater viral load reductions observed as the NM levels ...
Researchers develop new way to see single RNA molecules inside living cells
... target and follow native RNA and non-engineered viral RNA in living cells. "The great thing about ... transient interactions between proteins and viral RNA molecules that I don't think had ever been ... "We saw one of the proteins move into a viral RNA granule and reside within it for over a ...... but without the genetic material required for viral replication. Once injected into the body, VLPs ... Because they more closely match an individual viral strain, VLPs can trigger a more robust immune ... vaccine against it. Because VLPs do not contain viral nucleic acids (DNA or RNA), they cannot ...
Viroblock SA Reports Positive Results of Preclinical Studies in Antiviral Nasal Spray
... by altering and destabilizing cholesterol-rich viral envelopes. The two pre-clinical studies ... and allegedly limits the development of any viral resistance, and makes it effective on all ... of action that limits the development of any viral resistance and toxicity. VCCD Tech products exist ...Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis
... product for active immunization against viral infections of Japanese Encephalitis. IXIARO is ... Japanese Encephalitis is the leading cause of viral neurological disease and disability in Asia and the most important viral encephalitis in Asia. The disease is most common ...Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates
... proteins. In HCV care, the device inhibits viral replication through selective elimination of HCV ... from over 20 HCV treatments indicates an average viral load reduction of 41% during each four-hour ... treatment. In the studies, average pre-treatment viral load of 22,868,000 HCV virus copies/ml blood ...Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections
... in preclinical development for the treatment of viral hemorrhagic fevers under a contract worth up to ... in HIV, cytomegalovirus (CMV) and other serious viral infections. "Based on these findings, ... of drugs for the treatment of life-threatening viral infections," said study co-author Dr. Philip ...GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results
... also presented these same results at the viral Vector Vaccines 2008 meeting, at the Wellcome ... with from 100 to 1000 times reduction in viral levels. The excellent control of the ... for large scale production of the MVA viral vaccine. * In December 2008, GeoVax ...AcroMetrix Announces the Release of OptiQuant-S Hepatitis C Virus (HCV) Panel
... assays available in today's market. viral Hepatitis B and C now account for greater than ... for changes in the amount of virus (i.e. viral load) present in the patient when undergoing ... disease. Physicians rely on the accuracy of the viral load test result provided by the laboratory to ...Romark Announces Presentation of New Data for Controlled Release Nitazoxanide in Chronic Hepatitis C
... Pharmacokinetics and Significant Reduction in viral Load TAMPA, Fla., Feb. 17 /PRNewswire/ -- ... Release Tablet Improves Pharmacokinetics, viral Kinetics and Tolerability of Nitazoxanide for ... is developing other new thiazolides for treating viral diseases including chronic hepatitis B, herpes ...Vaccine Against the Chikungunya Virus in Development by a Public-Private Partnership
... reduce the rate of Chikungunya infections. viral disease epidemics have increased in incidence ... have extensive expertise in the field of exotic viral infectious diseases as well as significant ... by the year 2012. Chikungunya is a serious viral illness, which is transmitted by the Asian tiger ...... substrate for the production of numerous viral vaccines such as flu or MVA based vaccines but ... drugs for the prevention and treatment of viral diseases. VIVALIS's expertise and intellectual ... and biotechnology companies for the production of viral vaccines. Vivalis receives up front, milestones, ...
Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
... an increase in CD4+ T-cell counts, a reduction in viral load and expansion of CCR5-modified T-cells, ... of ZFN-modified cells, CD4+ cell counts and viral load. Individuals interested in participating in ... and a statistically significant reduction in viral load in their peripheral blood (P<0.001) ...SAFC Pharma Augments Assay Development Capabilities
... adjacent to the Company's existing flagship viral substance production facility, the new ... in important emerging new technologies such as viral vaccines and gene therapies - areas where SAFC ... high-potency APIs, solid-state chemistry, viral products and chemical-biologic API conjugates. ...... product for active immunization against viral infections of Japanese Encephalitis. The vaccine ... Japanese Encephalitis is the leading cause of viral neurological disease and disability in Asia and the most important viral encephalitis in Asia. The disease is most common ...
Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections
... in preclinical development for the treatment of viral hemorrhagic fevers under a contract worth up to ... in HIV, cytomegalovirus (CMV) and other serious viral infections. "Based on these findings, ... of drugs for the treatment of life-threatening viral infections," said study co-author Dr. Philip ...... 13-14, 2008 that can accurately predict which viral strains are poised to attack human populations, and reveal the location from which this viral strain is going to strike. This service is being ... which are susceptible to several devastating viral diseases. The replikin-based vaccine developed by ...
Russia Chooses Inactivated Polio Vaccine from Sanofi Pasteur for Primary Immunization of all Infants
... of M.P. Chumakov Institute of Poliomyelitis and viral Encephalitides Russian Academy Medical Sciences. ... M.P. Chumakov Institute of Poliomyelitis and viral Encephalitides The Institute of Poliomyelitis ... and became Institute of Poliomyelitis and viral Encephalitides. Inactivated polio Salk vaccine ...Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results
... once-daily IDX899 achieved a mean plasma viral load reduction of approximately 1.8 log10 after ... Patients receiving placebo (n=8) had a mean viral load increase of 0.10 log10 over the same ... of drugs for the treatment of human viral and other infectious diseases. Idenix's current ...Anadys Pharmaceuticals Commences Dosing ANA773 in Hepatitis C Patients
... for subsequent cohorts will be selected based on viral load and tolerability data from the 800 ... complementary HCV programs advancing toward viral load data, we look forward to demonstrating ... for subsequent cohorts will be selected based on viral load and tolerability data from the 800 ....... Immune Cells after HIV Infection and Reduced viral Loads WASHINGTON and RICHMOND, Calif., Oct. 28 ... increase in CD4 T-cell counts and a reduction in viral load in an animal model of HIV infection. ... significant seven-fold reduction in viral load in their peripheral blood (P<0.001) compared ...
Advanced Viral Announces Phase IIb Wound Healing Trial for AVR123
... in the amount of $249,500. About Advanced viral Research Corp. Advanced viral Research Corp. is a biopharmaceutical company ... For further information regarding Advanced viral Research Corp., please visit the website at ...... objectives of the study included evaluation of viral shedding, mortality, clinical relapse and time ... in time weighted change from baseline in viral titer, zero mortality, no clinical relapse and a ... tests, peramivir has shown activity against viral strains that are resistant to currently available ...
Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights
... a period of three days. Anadys expects to have viral load data from this study in the first quarter of ... for subsequent cohorts will be selected based on viral load and tolerability data from the 800 mg ... future clinical trials, the timing for obtaining viral load data and expectations regarding such data, ...Laureate Announces Manufacturing Agreement with Tolerx
... currently in development for cancer and chronic viral indications. Details of the agreement were ... for the treatment of cancer and chronic viral diseases. TRX518 is thought to circumvent ... cells, thereby enhancing responses to tumor and viral antigens. Tolerx also has two antibodies ...Other ContentshyperreflexiaautosomalautosomalautosomalautosomalautopsyautopsyautopsyaxillaanthracisanthracisanthracisbabesiosisbottlebottlebottlebottlebottlebottleOther TagsGlycolLeeLeeLeeLeeLeeLeeLeeOther Tagsinformation 2information 3information 4information 5information 6information 7information 8information 9information 10countries 2countries 3countries 4countries 5countries 6countries 7countries 8countries 9countries 10free 2free 3free 4free 5free 6free 7free 8free 9free 10body 2body 3body 4body 5body 6body 7body 8body 9body 10cloning 2half 2half 3half 4half 5half 6half 7half 8half 9half 10cuts 2
(Date:12/1/2009)...i, winner of the 2009 Inserm Grand Prix., Every ...t to paying tribute to outstanding,work performed... talents, Inserm intends to,demonstrate the diver...biological, medical and,health research, and the ...rry out and,drive this research each day. The Ins...
(Date:12/1/2009)...ash. -- Time-lapsed video of individual breast tis... life of a cell: a protein that cycles between two...researchers a more complete view of the internal s...nts that go awry in cancer and are targets of drug...lls respond to growth factors, travels back and fo...
(Date:11/30/2009)...ehensive review of the state of Antarctica,s clima...em is published this week (Tuesday 1 December) by ...AR). The review - Antarctic Climate Change and th...he icy continent, identifies areas for future scie...s that policy makers have about Antarctic melting,...
Breaking Biology News(10 mins):Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 2ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 3ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 4First comprehensive review of the state of Antarctica's climate 2The Kidney TRUST 26apos 3Bs Chronic Kidney Disease Rapid Screening Program Hits 10 000 54064 1The Kidney TRUST 26apos 3Bs Chronic Kidney Disease Rapid Screening Program Hits 10 000 54064 2NACDS Pharmacy and Technology Conference Focuses on Reform 54062 1NACDS Pharmacy and Technology Conference Focuses on Reform 54062 2NACDS Pharmacy and Technology Conference Focuses on Reform 54062 3NACDS Pharmacy and Technology Conference Focuses on Reform 54062 4Blue Cross and Blue Shield of Illinois Announces One Millionth E Prescription in Illinois 54060 1Blue Cross and Blue Shield of Illinois Announces One Millionth E Prescription in Illinois 54060 2Blue Cross and Blue Shield of Illinois Announces One Millionth E Prescription in Illinois 54060 3Blue Cross and Blue Shield of Illinois Announces One Millionth E Prescription in Illinois 54060 4(Date:12/2/2009)... 3D animation detailing plastic surg...ements website. Surgical candidates can view proce...y from the page. , (PRWEB... compression garments retailer, has always been de... patients after their procedures, providing liposu...
(Date:12/2/2009)... myEMRchoice.com Enables Personal He... Fort Washington, PA (PRWEB) Decemb...ive consumers is to read their own medical records...keeping control of personal medical records is eas... PA based healthcare technology company has added ...
(Date:12/2/2009)... Award-winning author James A. Feins...book, Short White Coat: Lessons from Patients on B...h the third year of medical school--the grueling c...HIA, PA (PRWEB) December 2, 2009 -- Most people w...ves dressed in a tiny hospital gown or staring at ...
(Date:12/2/2009)... Leading medical device software eng...s received ISO 13485 certification. A relatively f...firms have actually achieved ISO 13485 certificati...ification and adhere to other ISO standards as wel...ce software engineering consulting firm to achieve...
(Date:12/2/2009)..., SAN DIEGO, Dec. 2 Gen-...t the 21st Annual Piper Jaffray Health Care Confer...tion is scheduled to be webcast live and may be ac...Gen-Probe,s website at www.gen-probe.com . The we...event. ,, About Gen-Probe ,, Gen-Probe In...
Breaking Medicine News(10 mins):Health News:Online Compression Garments Retailer Introduces 3D Animation of Surgical Procedures 2Health News:Personal Health Records On-Demand, In Your Pocket 2Health News:Beneath the Short White Coat: A Medical Student Reveals All 2Health News:Medical Device Software Engineering Consulting firm Full Spectrum Software Earns ISO 13485 Certification 2Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2[0] Online Compression Garments Retailer Introduces 3D Animation of Surgical Procedures [0] Personal Health Records On-Demand, In Your Pocket [0] Beneath the Short White Coat: A Medical Student Reveals All[0] Medical Device Software Engineering Consulting firm Full Spectrum Software Earns ISO 13485 Certification[0] Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |